STOCK TITAN

Amlan International to Showcase Swine Gut Health Innovations at AMVECAJ 2026 in Partnership with KOFARM

Amlan International (NYSE: ODC) will exhibit at the XXXII AMVECAJ International Congress in Tepatitlán de Morelos, Jalisco, Mexico, on Feb 4–6, 2026, co‑sponsoring the event with distribution partner KOFARM and staffing Booth 14.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
partnership

Amlan International (NYSE: ODC) will exhibit at the XXXII AMVECAJ International Congress in Tepatitlán de Morelos, Jalisco, Mexico, on Feb 4–6, 2026, co‑sponsoring the event with distribution partner KOFARM and staffing Booth 14.

The company will showcase natural, mineral‑based swine feed additives including Calibrin‑Z and Varium, share technical and field data on gut health in antibiotic‑free systems, and invite producers to discuss trials and integration into commercial programs.

Loading...
Loading translation...
Argus Feb 3 session
+0.67% close to close Open Argus
Details

News Market Reaction – ODC

On Feb 3, the first trading day after this news, ODC closed 0.67% above the previous close.

Data tracked by StockTitan Argus for the Feb 3 session.

Key Figures

AMVECAJ 2026 dates: February 4–6, 2026 Booth location: Booth 14
AMVECAJ 2026 dates
February 4–6, 2026
XXXII AMVECAJ International Congress
Booth location
Booth 14
Amlan exhibit with KOFARM at AMVECAJ 2026

Previous Partnership Reports

3 past events · Latest: Jul 07
Same Type 3 events
  1. Jul 07

    Brazil partnership

    24h Move
    -4.0%

    Strategic Boviz deal to distribute cattle feed additives in Brazil.

  2. Feb 28

    LatAm distributor deal

    24h Move
    +1.1%

    New Grupo Profil distribution partnership for gut health solutions.

  3. Feb 06

    KOFARM AMVECAJ 2024

    24h Move
    +2.1%

    Collaboration with KOFARM to showcase swine gut health solutions.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

gut integrity, pathogen pressure, antibiotic-free production systems
3 terms
gut integrity medical
"solutions designed to support gut integrity, optimize nutrient utilization"
Gut integrity is the condition of the digestive tract’s lining and its ability to absorb nutrients while blocking harmful microbes and toxins. Investors care because products, drugs or foods that improve or harm gut integrity can change market demand, clinical trial outcomes, regulatory decisions and operational costs—like a fence around a garden: a strong fence keeps pests out and crops healthy, while a broken one lets problems spread and reduces yield.
pathogen pressure medical
"manage real world challenges such as pathogen pressure, feed efficiency losses"
Pathogen pressure is the level of threat posed by disease-causing organisms — how often and how intensely they infect a population, crop, or herd. For investors, it signals potential impacts on sales, costs and regulatory scrutiny for companies in healthcare, agriculture and food supply chains; high pathogen pressure can be like heavy, repeated rain that forces firms to spend more on treatments, recalls or new products to stay afloat.
antibiotic-free production systems medical
"improve overall animal performance in antibiotic-free production systems"
A system where farmed animals or food products are raised and processed without the use of antibiotics for growth promotion or routine disease prevention. Investors care because it affects costs, regulatory exposure, and consumer demand — like choosing organic produce, it can command higher prices but may raise production risk and require different supply-chain practices, influencing margins, brand value, and long-term sales trends.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CHICAGO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Amlan® International, the animal health business of Oil-Dri® Corporation of America (NYSE: ODC), will exhibit at the XXXII AMVECAJ International Congress, taking place from February 4-6, 2026, in Tepatitlán de Morelos, Jalisco, Mexico. Amlan will be located at Booth 14, co-sponsoring the event alongside its valued distribution partner KOFARM, reinforcing a shared commitment to advancing swine gut health and production performance across Mexico.

At AMVECAJ 2026, Amlan will highlight its proven portfolio of natural, mineral-based feed additives for swine, with a product focus on Calibrin®-Z and Varium® — solutions designed to support gut integrity, optimize nutrient utilization, and improve overall animal performance in antibiotic-free production systems.

“AMVECAJ is a critical platform for engaging directly with Mexico’s swine industry, and we are proud to once again collaborate with KOFARM to bring science-backed, practical solutions to producers,” said Dr. Robin Jarquin, Vice President of Sales, Latin American of Amlan International. “Our technologies are built to help producers manage real world challenges such as pathogen pressure, feed efficiency losses, and gut health instability, while supporting long term profitability.”

Throughout the congress, the Amlan and KOFARM teams will share technical insights, field experiences, and performance data demonstrating how targeted gut health strategies can drive measurable production outcomes. Attendees are invited to visit Booth 14 to connect with Amlan experts, explore collaborative trial opportunities, and learn how these solutions can be integrated into swine production programs.

Amlan’s presence at AMVECAJ 2026 underscores the company’s continued investment in Latin America and its commitment to supporting regional producers with innovative, natural feed technologies that deliver consistent results under commercial conditions.

About Amlan International
Amlan is the animal health business of Oil-Dri Corporation of America, a leading global manufacturer and marketer of sorbent minerals. Leveraging over 80 years of expertise in mineral science, Oil-Dri Corporation of America, doing business as “Amlan International,” is a publicly traded stock on the New York Stock Exchange (NYSE: ODC). Amlan International sells feed additives worldwide. Product availability may vary by country; associated claims do not constitute medical claims and may differ based on government requirements.

Contact:
Reagan Culbertson, Vice President of Strategic Marketing, B2B
Reagan.culbertson@amlan.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When and where will Amlan (ODC) present at AMVECAJ 2026?

Amlan will exhibit at AMVECAJ from February 4–6, 2026 in Tepatitlán de Morelos, Jalisco, Mexico. According to the company, representatives will staff Booth 14 and co‑sponsor the congress with KOFARM.

What Amlan products will be highlighted at AMVECAJ 2026 and what do they target?

Amlan will highlight Calibrin‑Z and Varium, targeting gut integrity and nutrient utilization in swine. According to the company, these mineral‑based additives support performance in antibiotic‑free production and help manage pathogen pressure and feed efficiency losses.

How can swine producers engage with Amlan (ODC) at AMVECAJ 2026?

Producers can visit Booth 14 to meet Amlan experts, discuss collaborative trials, and review performance data. According to the company, the team will share technical insights and field experiences for integrating solutions into commercial programs.

Why is Amlan partnering with KOFARM for AMVECAJ 2026 and what is the focus?

The partnership with KOFARM aims to strengthen regional support for swine gut health in Mexico. According to the company, the collaboration emphasizes science‑backed, practical solutions and investment in Latin America to improve on‑farm results.

Keep reading